ArticleHistochemistry and cell biology2026
Altered expression of Toll-like receptor 9 in the lung tissue of adult mice generated by in vitro embryo culture and embryo transfer.
Article in Histochemistry and cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Children conceived through assisted reproductive technologies (ART) are more sensitive to asthma and allergic respiratory diseases compared with children born through natural pregnancy. Growing evidence suggests that Toll-like receptors (TLRs) play a role in asthma. We previously demonstrated that TLR9 expression is significantly downregulated in the lung tissue of mouse fetuses generated through ART. The present study therefore investigated whether altered expression of TLR9 is maintained in the lung tissue in the perinatal period and in adult mice conceived through in vitro embryo culture and embryo transfer. We also examined the expression pattern of TLR9 in lung tissue. The study comprised one control (CG) and one experimental group (EG). Mice comprising EG were generated through the transfer of in vitro-derived F2 blastocysts. Mice obtained from naturally ovulated females served as the CG. Quantitative real-time PCR (qRT-PCR) and immunohistochemistry/immunofluorescence analyses were employed to determine the expression of TLR9. qRT-PCR analyses demonstrated that expression of TLR9 decreased 1.38-fold in EG when compared with the CG. Immunohistochemistry/immunofluorescence analyses revealed that the expression pattern of TLR9 is similar between the groups. Simultaneous staining of sequential sections further elucidated that TLR9 is expressed in type II alveolar epithelial cells. It therefore appears that altered expression of TLR9 observed in the lung tissue of mouse fetuses generated through embryo culture and embryo transfer persists into adulthood. To what extent the findings of the present study apply to human ART warrants further investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.